Loading, please wait...
Opioid Training Initiative: Inpatient FocusThis Opioid Training Initiative course was developed to provide healthcare professionals who work primarily in inpatient settings training to identify opioid use disorder (OUD), understand harm reduction best practices, develop and implement opioid stewardship programming, review non-opioid alternatives for pain management in the inpatient setting, discuss innovative models for inpatient treatment of OUD and review management of medications for OUD during hospitalization.
This course includes six unique one hour video modules on each key topic. Healthcare professionals are welcome to take one or all of the modules based on professional need but are encouraged to complete all modules to gain a full conceptual understanding. The information in this course has been specifically tailored to meet the needs of clinicians practicing in Texas with a focus on regional trends, laws and regulations.
|
All modules are accredited for CME, CPE, CNE, and CEUs' for social work and counselors. See full list of CE information below. The interprofessional nature of the content it meant to provide healthcare teams a comprehensive and team-based approach in treating OUD.
The following modules are included in this course. See the tabs below for more information on each module, and, once registered, for access to the module content.
Each module consists of an MP4 format video along with presentation slides in PDF format. Some modules include links to referenced programs and additional resources. Videos appear in the modules tabs below after registration. Learners may take one or all of the modules. CE credit is awarded upon completion of the evaluation. Credit accumulates as modules are completed. For pharmacy CPE, credits will be awarded to the NABP eprofile of the learner. For all others, once you complete each module, credit is added to the certificate. Click on the link at the top of the page "View/Print CE Credit". This certificate remains available in the learner's profile. Bookmark this page for easy return access while working through the various modules. At anytime, please feel free to email the UT College of Pharmacy Continuing Education Office at UTpharmacyCE@austin.utexas.edu for assistance.
Special thank you to the following faculty who developed the content of this course. Additional biography and disclosure information is available in the module tabs.
 |
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This online activity is approved for 0.6 CEUs (6.00 contact hours) of continuing education credit. In order to receive 6.00 contact hours of CE credit, the participant must watch all videos in their entirety, complete the online post-tests, and complete online evaluations. Credit will be awarded per module completed. Please make sure NABP profile and date of birth (month/year) are correct under learner's profile in this system. |
The UT Health San Antonio Joe R. & Teresa Lozano Long School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Long School of Medicine designates this material for a maximum of 6.0 AMA PRA Category 1 Credit™ .
CNE Disclosure to Participants
Accreditation Statement: University of Texas at Austin School of Nursing is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Requirements for Successful Completion: To receive contact hours for this continuing education activity, the participant must sign in or be registered for the event, attend the entire activity, and complete and submit the evaluation form. Once successful completion has been verified, a “Certificate of Successful Completion” will be awarded for 1 contact hour for each of the modules completed in either the Inpatient or Outpatient bundled modules.
The activity’s Nurse Planner has determined that no one who has the ability to control the content of this CNE activity – planning committee members and presenters/authors/content reviewers – has a conflict of interest or if any conflict was found, it was resolved prior to the activity.
This activity expires August 1, 2025.
The Office of Professional Development at The University of Texas at Austin Steve Hicks School of Social Work is accredited by the Council on Social Work Education, and as such receives automatic approval as a continuing education provider by the Texas Board of Social Work Examiners under Texas Administrative Code, Title 22, Part 34. § 781.511(c). The program represented by this certificate was provided in accordance with the criteria and standards of the Texas State Board of Social Worker Examiners, and has been approved for Social Workers, Licensed Professional Counselors, and Licensed Marriage and Family Therapists. Please note that 1 hour = 1 CEU. Complaints about this program may be made to TSBSWE 333 Guadalupe St, Tower 3, Room 900, Austin, TX 78701 • 512-305-7700 • 800-821-3205
| This project is funded by Texas Health & Human Services Texas Targeted Opioid Response. |
From Survival to Recovery in Opioid Use DisorderLucas G. Hill, PharmD, BCACP
Clinical Assistant Professor, The University of Texas at Austin College of Pharmacy
Director, Pharmacy Addictions Research & Medicine (PhARM) Program
|
In this module, Dr. Hill describes best practices for opioid overdose prevention, compares FDA-approved medications for opioid use disorder, and discusses current controversies and ethical issues in opioid use disorder treatment.
**Note: This module may be counted as one hour of CE related to Prescribing and Monitoring Controlled Substances, as outlined by (TSBP rule 295.8(d)(1)(C)) and (TMB criteria).
FACULTY
Lucas G. Hill, PharmD, BCPS, BCACP, graduated from the University of Missouri-Kansas City School of Pharmacy and completed a combined family medicine residency and faculty development fellowship in the University of Pittsburgh Medical Center St. Margaret Department of Family Medicine. He is now a clinical assistant professor at The University of Texas at Austin (UT) College of Pharmacy. Dr. Hill is the director and principal investigator of Operation Naloxone, an interprofessional opioid overdose prevention program funded through the Texas Targeted Opioid Response. His research is focused on clinician-community collaborations to address substance use disorders through evidence-based treatment and harm reduction strategies. Dr. Hill coordinates the first year of the UT Foundations for Interprofessional Collaborative Practice curriculum and serves as lead instructor for a module that trains students from pharmacy, medicine, nursing, and social work to provide team-based care for patients with addiction. He provides an additional 16 hours of addiction-related instruction in the required pharmacy curriculum and precepts both the overdose prevention introductory pharmacy practice experience and the addiction medicine advanced pharmacy practice experience. Dr. Hill currently serves as chair-elect of the American Association of Colleges of Pharmacy Substance Use Disorder Special Interest Group. He is also faculty advisor for the UT Student Pharmacist Recovery Network and co-chair for the UT Opioid Response Consortium. In 2020, Dr. Hill was awarded the American Pharmacists Association Generation Rx Award of Excellence in recognition of his outstanding contributions to addiction-related education.
DISCLOSURE: Dr. Hill receives financial support from the Substance Abuse and Mental Health Services Administration and the Texas Health and Human Services Commission via the Texas Targeted Opioid Response.
LEARNING OBJECTIVES
| This project is funded by Texas Health & Human Services Texas Targeted Opioid Response. |
Harm Reduction Basics for Healthcare ProfessionalsClaire Zagorski, MSc, LP
Program Coordinator and Harm Reduction Instructor, Director, Longhorn Stop the Bleed College of Pharmacy Dell Medical School The University of Texas at Austin |
In this module, Claire Zagorski describes the fundamentals of harm reduction, reviews the historical and modern-day context surrounding drug use in the United States, and describes the three waves of the current opioid crisis. Illicit drug use is a reality. It has been present throughout history. There are very real and significant dangers directly associated with illicit drug use as known today. Harm reduction can be adapted to reflect specific needs of both individuals and the community. In this module, various strategies of harm reduction are discussed, including stigma reduction, reducing chances of withdrawal in the hospital setting, availability of naloxone, buprenorphine diversion, and the use of person-centered motivational interviewing skills in treatment.
FACULTY
Claire Zagorski is a licensed paramedic with eight years of high volume, high acuity, urban ED experience. She is the Program Coordinator and Harm Reduction Instructor for the PhARM Program at The University of Texas at Austin College of Pharmacy and Founder and Director of Longhorn Stop the Bleed, bringing simple, free and accessible trauma response training to The University of Texas at Austin community. She has seven years of hands-on experience in harm reduction practice, advocacy and research, and is the former Coordinator of the Health Leadership Apprentice Program, a student research and professional development program for future healthcare leaders at Dell Medical School. Claire is a current MScPH student at the London School of Hygiene and Tropical Medicine. She has her MS in medical sciences from The University of North Texas Health Science Center and her BA in anthropology from The University of Texas at Austin.
DISCLOSURE: Claire Zagorski receives financial support from the Substance Abuse and Mental Health Services Administration and the Texas Health and Human Services Commission via the Texas Targeted Opioid Response.
LEARNING OBJECTIVES
| This project is funded by Texas Health & Human Services Texas Targeted Opioid Response. |
Developing and Implementing an Opioid Stewardship ProgramDouglas R. Oyler, PharmD
Assistant Professor University of Kentucky College of Pharmacy
|
In this module, Dr. Oyler describes the development, implementation, and evaluation of an opioid stewardship program in a large academic health center, including a discussion on the importance of developing a program. He then identifies strategies to improve safe opioid use within health systems, and how to develop collaborative strategies with other state and local entities to improve opioid use throughout their community.
* Note: This module may be counted as one CE hour relating to Prescribing and Monitoring Controlled Substances as specified by (TSBP rule 295.8(d)(1)(C))and (TMB criteria).
FACULTY
Dr. Oyler is an assistant professor in the Department of Pharmacy Practice and Science who serves as the Director of the Office of Opioid Safety at the University of Kentucky. In this role, where he leads the institution’s opioid stewardship program, including development, implementation, and evaluation of strategies to improve safe opioid use within the health system. He has collaborated with the Kentucky Hospital Association, KASPER, the Center on Drug and Alcohol Research, and numerous other state and local entities to improve opioid use throughout the state. His work in opioid stewardship has been featured in the American Journal of Health System Pharmacy, the Journal of Opioid Management, and the Journal of Trauma and Acute Care Surgery, among others. Dr. Oyler graduated from the University of Kentucky College of Pharmacy in 2010, where he then completed a pharmacy practice residency, a critical care specialty residency, and a fellowship in academia.
DISCLOSURE: Dr. Oyler has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.
LEARNING OBJECTIVES
| This project is funded by Texas Health & Human Services Texas Targeted Opioid Response. |
The B-Team: An Innovative Model for Inpatient Treatment InitiationKirsten Mason, PharmD, BCPS
Clinical Pharmacy Manager | Seton Healthcare Family
Richard Bottner, PA-C
Affiliate Faculty, Division of Internal Medicine| Dell Medical School
|
In this module, Kristen Mason and Richard Bottner describe the development and implementation of an OUD treatment service led by internal medicine clinicians in collaboration with a broad range of interprofessional team members. They then discuss how to develop or expand similar services by engaging a variety of professionals in your institution.
FACULTY
Kirsten Roberts Mason, PharmD, BCPS is a graduate of the University of Tennessee Health Science Center College of Pharmacy. She completed a PGY1 Pharmacy Residency at Memphis Veterans Affairs Medical Center and her PGY2 Internal Medicine Residency at University Medical Center Brackenridge in Austin, TX. Immediately after residency training, Dr. Mason accepted a Clinical Pharmacy Specialist position in cardiology at Northwestern Memorial Hospital in Chicago. In 2016, she had an opportunity to relocate back to Austin and she joined Dell Seton Medical Center at University of Texas as an Internal Medicine Clinical Pharmacy Specialist. In this role, she assisted in the development of an inpatient opioid use disorder treatment service. In November of 2018, Dr. Mason transitioned roles within Ascension Texas to a Regional Clinical Pharmacy Manager with an emphasis on project management and pain management. She also serves as a student preceptor for University of Texas College of Pharmacy and Texas A&M College of Pharmacy.
Richard Bottner, PA-C is a physician assistant in the division of hospital medicine and department of internal medicine at Dell Medical School at the University of Texas Austin. For the past two years, Rich has been the Director of Support Hospital Opioid Use Treatment (SHOUT) Texas – a program which supports patients with substance use disorders during hospitalization. This is the only program of its kind in the state. Rich is a national trainer for medications to treat opioid use disorder through the American Academy of Addiction Psychiatry. Rich is a past president of the Central Texas PA Society and current co-chair of the Substance Use Disorder Special Interest Group of the Society of Hospital Medicine. He is currently pursuing a Doctor of Health Administration degree from the Medical University of South Carolina.
DISCLOSURE: Kristen Mason has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.
DISCLOSURE: Ricard Bottner has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.
LEARNING OBJECTIVES
| This project is funded by Texas Health & Human Services Texas Targeted Opioid Response. |
Non-Opioid Alternatives for Pain Management in the Hospital SettingDouglas R. Oyler, PharmD
Assistant Professor University of Kentucky College of Pharmacy
|
In this module, Dr. Oyler covers the role of various non-opioid analgesics in hospital-based pain management, and discusses how to implement pain management strategies that incorporate non-opioid and opioid analgesics.
* Note: This module may be counted as one CE hour relating to Pain Management as specified by (TSBP rule 295.8(d)(1)(B)) and TMB criteria.
FACULTY
Dr. Oyler is an assistant professor in the Department of Pharmacy Practice and Science who serves as the Director of the Office of Opioid Safety at the University of Kentucky. In this role, where he leads the institution’s opioid stewardship program, including development, implementation, and evaluation of strategies to improve safe opioid use within the health system. He has collaborated with the Kentucky Hospital Association, KASPER, the Center on Drug and Alcohol Research, and numerous other state and local entities to improve opioid use throughout the state. His work in opioid stewardship has been featured in the American Journal of Health System Pharmacy, the Journal of Opioid Management, and the Journal of Trauma and Acute Care Surgery, among others. Dr. Oyler graduated from the University of Kentucky College of Pharmacy in 2010, where he then completed a pharmacy practice residency, a critical care specialty residency, and a fellowship in academia.
DISCLOSURE: Dr. Oyler has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.
LEARNING OBJECTIVES
| This project is funded by Texas Health & Human Services Texas Targeted Opioid Response. |
|
Managing Medications for Opioid Use Disorder During Hospitalization
Kirsten Mason, PharmD, BCPS, PharmD, PCPS
Clinical Pharmacy Manager | Seton Healthcare Family
Amanda Simonton, MSN, RN, PMHNP-BC
PhD Candidate, Psychiatric-Mental Health Nurse Practitioner, CARMAhealth |
In this module, Kristen Mason and Amanda Simonton review case examples that demystify management of FDA-approved medications for opioid use disorder in various inpatient treatment scenarios. They focus on clinical and peer-reviewed based data to help provide a general understanding of these medications. They also discuss strategies to effectively navigate pain management, peri-operative care, and other potentially complicated situations. This includes use of alternative pain management approaches, as well as information on how to reduce patient abuse or withdrawals.
*Note: This module may be counted as one hour of CE related to Prescribing and Monitoring Controlled Substances - OR - this module may be counted as one hour of CE related to Pain Management, as outlined by (TSBP rule 295.8(d)(1)(C)), (TSBP rule 295.8(d)(1)(B)), and (TMB criteria).
Pharmacist Note: Per TSBP, pharmacists may not use one CE activity to count towards two different TSBP subject requirements.
FACULTY
Kirsten Roberts Mason, PharmD, BCPS is a graduate of the University of Tennessee Health Science Center College of Pharmacy. She completed a PGY1 Pharmacy Residency at Memphis Veterans Affairs Medical Center and her PGY2 Internal Medicine Residency at University Medical Center Brackenridge in Austin, TX. Immediately after residency training, Dr. Mason accepted a Clinical Pharmacy Specialist position in cardiology at Northwestern Memorial Hospital in Chicago. In 2016, she had an opportunity to relocate back to Austin and she joined Dell Seton Medical Center at University of Texas as an Internal Medicine Clinical Pharmacy Specialist. In this role, she assisted in the development of an inpatient opioid use disorder treatment service. In November of 2018, Dr. Mason transitioned roles within Ascension Texas to a Regional Clinical Pharmacy Manager with an emphasis on project management and pain management. She also serves as a student preceptor for University of Texas College of Pharmacy and Texas A&M College of Pharmacy.
Amanda Simonton is a Psychiatric Mental Health Nurse Practitioner in Austin, TX. She works at CARMAhealth, an outpatient clinic that provides primary and psychiatric care to individuals with dual-diagnosis – substance use and psychiatric disorders. She earned her Master’s and Bachelor’s degrees in Nursing at the University of Texas at Austin and is currently a PhD candidate at the University of Texas at Austin, graduating May 2020. Her research and clinical interests are to improve the lives of those with substance use disorders, particularly opioid use disorder. Amanda has worked as a teaching assistant at UT Austin and has taught undergraduate and graduate level students nursing skills, including how to give intramuscular injections. Additionally, she has been a Registered Nurse for 7 years and has hands-on experience implementing these skills during her work as a bedside nurse in an intermediate care unit and psychiatric emergency department.
DISCLOSURE: Kristen Mason has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.
DISCLOSURE: Amanda Simonton has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.
LEARNING OBJECTIVES
| This project is funded by Texas Health & Human Services Texas Targeted Opioid Response. |